TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DNTH

Dianthus Therapeutics Inc.

Healthcare · Biotechnology · —

98.40$ +1.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Dianthus Therapeutics Inc. (DNTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,213 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DNTH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
192 179 382 369 354 374 349 326 577 531 1,247 1,213
191 177 381 366 287 281 271 264 414 409 1,120 898
157 132 330 314 34 23 10 13 56 51 628 111
190 174 377 361 281 275 263 257 403 404 1,111 887
0.8 0.5 0.9 1.7 1.3 0.8 1.0 0.0 5.0 0.1 1.2 0.1
2.3
14 11 9.8 11 16 22 20 23 31 38 46 41
13 9.6 9.0 10 16 18 17 20 24 31 38 34
0.4 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.4 0.4 0.4
1.4 2.6 2.6 3.7 7.6 4.6 8.3 5.4 6.7 9.7 5.3 6.4
178 169 373 358 338 352 329 303 546 493 1,201 1,172
-79 -89 -103 -121 -146 -174 -204 -236 -272 -337 -378 -428
39 4.5 26 34 34 35 36 36 38 38 48 56

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?